13FPulse
中
AT

ATNM ACTINIUM PHARMACEUTICALS INC

2026Q2 · CUSIP 00507W206 · Sector: Healthcare & Biotech

Normal

Fund flows are within the usual range

Funds that own it
47
Institutions that reported holding it to the SEC
Net decrease in holders
6
Last quarter 53 → now 47
How unusual is that
Bottom 20%
Stronger than only 19% of US stocks
What the filings say, in one paragraph

47 funds held ATNM at the end of 2026Q2, down 6 from the quarter before. Fund flows are within the usual range — nothing unusual. On the business itself, the P/E is 2.9x, return on equity is 37.3%. ATNM has had 2 buying rushes in its history. It sits in the Healthcare & Biotech sector.

How many funds owned it, quarter by quarter

Bars = net change in institutional holders, positive (green) or negative (red). Line = total institutional holders.

2020Q2: holders=1 2020Q3: holders=40 2020Q4: holders=47 2021Q1: holders=39 2021Q2: holders=37 2021Q3: holders=43 2021Q4: holders=42 2022Q1: holders=37 2022Q2: holders=50 2022Q3: holders=56 2022Q4: holders=59 2023Q1: holders=65 2023Q2: holders=71 2023Q3: holders=58 2023Q4: holders=59 2024Q1: holders=67 2024Q2: holders=74 2024Q3: holders=72 2024Q4: holders=69 2025Q1: holders=70 2025Q2: holders=64 2025Q3: holders=61 2025Q4: holders=60 2026Q1: holders=53 2026Q2: holders=47 -39 -19.5 +0 +19.5 +39 03978 20Q221Q121Q422Q323Q224Q124Q425Q326Q2 Net change in holders (bars) Total funds holding (line)

What happened after each past buying rush 2 times in its history

Quarter of the rush How unusual then Price, next 3 months Price, next 6 months
2022Q2 Top 20% — —
2020Q3 Top 5% — —

These are the raw price moves, not how much it beat the market by. Compare them against the market over the same months — in a strong bull market almost everything is up.

Show all the numbers (large funds, value held, options…) ▾
Of them, large funds
26
Change in large funds
-2
Total value they hold
$5M
Funds buying for the first time
8
Funds that sold out entirely
14
Price change that quarter
—
Funds holding puts (bearish)
0
Funds holding calls (bullish)
1

These are for people who want to dig. Skip them if they do not mean anything to you — the three numbers above are enough.

8,697 institutions have filed for this quarter. 13F permits late filing and a small number arrive in the weeks after the deadline, so the holder counts and changes below may tick up.

Fundamentals

PE (TTM)
2.9
EPS (TTM)
$0.35
EPS YoY
—
Revenue (TTM)
—
Revenue YoY
—
Net margin
—
ROE
37.3%
Debt ratio
24.5%
FCF (TTM)
—
Dividend (TTM)
No dividend
Quarterly Revenue & EPS
2021-09-30: EPS -0.30 2021-12-31: EPS -0.36 2022-03-31: EPS -0.23 2022-06-30: EPS -0.33 2022-09-30: EPS -0.38 2022-12-31: EPS -0.43 2023-03-31: EPS -0.43 2023-06-30: EPS -0.58 2023-09-30: EPS -0.49 2023-12-31: EPS -0.33 2024-03-31: EPS -0.31 2024-06-30: EPS -0.38 2024-09-30: EPS -0.37 2024-12-31: EPS -0.21 2025-03-31: EPS -0.51 2025-06-30: EPS -0.22 2025-09-30: EPS -0.16 2025-12-31: EPS -0.20 2026-03-31: EPS -0.18 2026-06-30: EPS 0.89 -0.64 0.17 0.98 20212022202320242025202606/26 EPS

Quarterly figures, revenue up to 10 years back; EPS split-adjusted, early quarters hidden when not calibrable

P/E (TTM) over time
3 3 3 2026

P/E = close around day 47 after quarter-end ÷ TTM EPS then; this is a consistent valuation date, not the company’s actual filing date; loss quarters hidden

Quarterly free cash flow
-15M6M28M 20162017201820192020202120222023202420252026
Latest quarter $-6M (2026-03-31)

FCF = operating cash flow − capex, computed from SEC XBRL; banks/insurers have no standard cash-flow structure and are hidden

As of 2026-06-30 · SEC filings (XBRL)

Email me the next update

2026 Q3 holdings are due 2026-11-16. We will email you when the refreshed lists are live.